BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38181713)

  • 1. Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application.
    Liu N; Chen M
    Biomed Pharmacother; 2024 Feb; 171():116115. PubMed ID: 38181713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper homeostasis and cuproptosis in mitochondria.
    Tian Z; Jiang S; Zhou J; Zhang W
    Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma.
    Shen Y; Li D; Liang Q; Yang M; Pan Y; Li H
    Front Immunol; 2022; 13():1029092. PubMed ID: 36733399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
    Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials.
    Wang J; Li J; Liu J; Chan KY; Lee HS; Lin KN; Wang CC; Lau TS
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy.
    Li Y; Liu J; Chen Y; Weichselbaum RR; Lin W
    Adv Sci (Weinh); 2024 Jun; 11(23):e2310309. PubMed ID: 38477411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer.
    Wang W; Lu K; Jiang X; Wei Q; Zhu L; Wang X; Jin H; Feng L
    J Exp Clin Cancer Res; 2023 Jun; 42(1):142. PubMed ID: 37277863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma.
    Liu Z; Ma H; Lai Z
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis and cuproptposis in kidney Diseases: dysfunction of cell metabolism.
    Chen T; Liang L; Wang Y; Li X; Yang C
    Apoptosis; 2024 Apr; 29(3-4):289-302. PubMed ID: 38095762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuproptosis: mechanisms and links with cancers.
    Xie J; Yang Y; Gao Y; He J
    Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death.
    Li Y; Du Y; Zhou Y; Chen Q; Luo Z; Ren Y; Chen X; Chen G
    Cell Commun Signal; 2023 Nov; 21(1):327. PubMed ID: 37974196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy - Significance for cancer treatment?
    Kciuk M; Gielecińska A; Kałuzińska-Kołat Ż; Yahya EB; Kontek R
    Biochim Biophys Acta Rev Cancer; 2024 Jul; 1879(4):189124. PubMed ID: 38801962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier-Free Self-Assembly Nano-Sonosensitizers for Sonodynamic-Amplified Cuproptosis-Ferroptosis in Glioblastoma Therapy.
    Zhu Y; Niu X; Ding C; Lin Y; Fang W; Yan L; Cheng J; Zou J; Tian Y; Huang W; Huang W; Pan Y; Wu T; Chen X; Kang D
    Adv Sci (Weinh); 2024 Jun; 11(23):e2402516. PubMed ID: 38582500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
    Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
    Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper homeostasis and cuproptosis in cancer immunity and therapy.
    Liu WQ; Lin WR; Yan L; Xu WH; Yang J
    Immunol Rev; 2024 Jan; 321(1):211-227. PubMed ID: 37715546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation of cuproptosis and ferroptosis in liver cancer.
    Mo JQ; Zhang SY; Li Q; Chen MX; Zheng YQ; Xie X; Zhang R; Wang SS
    Cancer Cell Int; 2024 Jan; 24(1):22. PubMed ID: 38200525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer.
    Liu X; Luo B; Wu X; Tang Z
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189013. PubMed ID: 37918452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of biomarkers co-associated with M1 macrophages, ferroptosis and cuproptosis in alcoholic hepatitis by bioinformatics and experimental verification.
    Hou S; Wang D; Yuan X; Yuan X; Yuan Q
    Front Immunol; 2023; 14():1146693. PubMed ID: 37090703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characteristics, clinical significance, and cancer immune interactions of cuproptosis and ferroptosis-associated genes in colorectal cancer.
    Li Y; Wang RY; Deng YJ; Wu SH; Sun X; Mu H
    Front Oncol; 2022; 12():975859. PubMed ID: 36132144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulus-Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer Immunotherapy.
    Hu F; Huang J; Bing T; Mou W; Li D; Zhang H; Chen Y; Jin Q; Yu Y; Yang Z
    Adv Sci (Weinh); 2024 Apr; 11(13):e2309388. PubMed ID: 38269649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.